|
J Biol Chem, Vol. 275, Issue 20, 15399-15406, May 19, 2000
Targeted Expression of Placental Lactogen in the Beta Cells of
Transgenic Mice Results in Beta Cell Proliferation, Islet Mass
Augmentation, and Hypoglycemia*
Rupangi C.
Vasavada §,
Adolfo
Garcia-Ocaña ,
Walter S.
Zawalich¶,
Robert L.
Sorenson ,
Pamela
Dann¶,
Mushtaq
Syed ,
Linda
Ogren**,
Frank
Talamantes**, and
Andrew F.
Stewart
From the Division of Endocrinology, University of
Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, the
¶ Yale University Schools of Nursing and Medicine, New Haven,
Connecticut 06520, the Department of Cell Biology and
Neuroanatomy, University of Minnesota School of Medicine, Minneapolis,
Minnesota 55455, and the ** Department of Biology, University of
California, Santa Cruz, California 95064
The factors that regulate pancreatic beta cell
proliferation are not well defined. In order to explore the role of
murine placental lactogen (PL)-I (mPL-I) in islet mass regulation
in vivo, we developed transgenic mice in which mPL-I is
targeted to the beta cell using the rat insulin II promoter. Rat
insulin II-mPL-I mice displayed both fasting and postprandial
hypoglycemia (71 and 105 mg/dl, respectively) as compared with normal
mice (92 and 129 mg/dl; p < 0.00005 for both). Plasma
insulin concentrations were inappropriately elevated, and insulin
content in the pancreas was increased 2-fold. Glucose-stimulated
insulin secretion by perifused islets was indistinguishable from
controls at 7.5, 15, and 20 mM glucose. Beta cell
proliferation rates were twice normal (p = 0.0005).
This hyperplasia, together with a 20% increase in beta cell size,
resulted in a 2-fold increase in islet mass (p = 0.0005) and a 1.45-fold increase in islet number (p = 0.0012). In mice, murine PL-I is a potent islet mitogen, is capable of increasing islet mass, and is associated with hypoglycemia over the
long term. It can be targeted to the beta cell using standard gene
targeting techniques. Potential exists for beta cell engineering using
this strategy.
*
This work was supported by National Institutes of Health
Grants DK 47168, DK 55023, DK 41230, DK 33655, and HD 14966.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: BST E-1140, University
of Pittsburgh Medical Center, 3550 Terrace St., Pittsburgh, PA 15213. Tel.: 412-648-9770; Fax: 412-648-3290; E-mail:
vasavada@msx.dept-med.pitt.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Sachdeva and D. A. Stoffers
Minireview: Meeting the Demand for Insulin: Molecular Mechanisms of Adaptive Postnatal ss-Cell Mass Expansion
Mol. Endocrinol.,
June 1, 2009;
23(6):
747 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Huang, F. Snider, and J. C. Cross
Prolactin Receptor Is Required for Normal Glucose Homeostasis and Modulation of {beta}-Cell Mass during Pregnancy
Endocrinology,
April 1, 2009;
150(4):
1618 - 1626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Lavine, P. W. Raess, D. B. Davis, M. E. Rabaglia, B. K. Presley, M. P. Keller, M. C. Beinfeld, A. S. Kopin, C. B. Newgard, and A. D. Attie
Overexpression of Pre-Pro-Cholecystokinin Stimulates {beta}-Cell Proliferation in Mouse and Human Islets with Retention of Islet Function
Mol. Endocrinol.,
December 1, 2008;
22(12):
2716 - 2728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Arumugam, E. Horowitz, D. Lu, J. J. Collier, S. Ronnebaum, D. Fleenor, and M. Freemark
The Interplay of Prolactin and the Glucocorticoids in the Regulation of {beta}-Cell Gene Expression, Fatty Acid Oxidation, and Glucose-Stimulated Insulin Secretion: Implications for Carbohydrate Metabolism in Pregnancy
Endocrinology,
November 1, 2008;
149(11):
5401 - 5414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Fiaschi-Taesch, D. M. Berman, B. M. Sicari, K. K. Takane, A. Garcia-Ocana, C. Ricordi, N. S. Kenyon, and A. F. Stewart
Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets
Diabetes,
October 1, 2008;
57(10):
2745 - 2754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Donath, J. Storling, L. A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen
Cytokines and {beta}-Cell Biology: from Concept to Clinical Translation
Endocr. Rev.,
May 1, 2008;
29(3):
334 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Beith, E. U. Alejandro, and J. D. Johnson
Insulin Stimulates Primary {beta}-Cell Proliferation via Raf-1 Kinase
Endocrinology,
May 1, 2008;
149(5):
2251 - 2260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fujinaka, K. Takane, H. Yamashita, and R. C. Vasavada
Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation
J. Biol. Chem.,
October 19, 2007;
282(42):
30707 - 30717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Alonso, T. Yokoe, P. Zhang, D. K. Scott, S. K. Kim, C. P. O'Donnell, and A. Garcia-Ocana
Glucose Infusion in Mice: A New Model to Induce {beta}-Cell Replication
Diabetes,
July 1, 2007;
56(7):
1792 - 1801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol.,
February 1, 2007;
38(2):
193 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Vasavada, I. Cozar-Castellano, D. Sipula, and A. F. Stewart
Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic {beta}-Cell Has Limited Effects on {beta}-Cell Replication, Mass, and Function
Diabetes,
January 1, 2007;
56(1):
57 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cozar-Castellano, M. Haught, and A. F. Stewart
The Cell Cycle Inhibitory Protein p21cip Is Not Essential for Maintaining {beta}-Cell Cycle Arrest or {beta}-Cell Function In Vivo
Diabetes,
December 1, 2006;
55(12):
3271 - 3278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden
Peroxisome Proliferator-Activated Receptor-{alpha} and Glucocorticoids Interactively Regulate Insulin Secretion During Pregnancy
Diabetes,
December 1, 2006;
55(12):
3501 - 3508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jackerott, A. Moldrup, P. Thams, E. D. Galsgaard, J. Knudsen, Y. C. Lee, and J. H. Nielsen
STAT5 Activity in Pancreatic {beta}-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes.
Diabetes,
October 1, 2006;
55(10):
2705 - 2712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Johansson, G. Mattsson, A. Andersson, L. Jansson, and P.-O. Carlsson
Islet Endothelial Cells and Pancreatic {beta}-Cell Proliferation: Studies in Vitro and during Pregnancy in Adult Rats
Endocrinology,
May 1, 2006;
147(5):
2315 - 2324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Kolonin, J. Sun, K.-A. Do, C. I. Vidal, Y. Ji, K. A. Baggerly, R. Pasqualini, and W. Arap
Synchronous selection of homing peptides for multiple tissues by in vivo phage display
FASEB J,
May 1, 2006;
20(7):
979 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cozar-Castellano, M. Weinstock, M. Haught, S. Velazquez-Garcia, D. Sipula, and A. F. Stewart
Evaluation of {beta}-Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental Lactogen: Comprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21cip
Diabetes,
January 1, 2006;
55(1):
70 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Lindberg, S G Ronn, D Tornehave, H Richter, J A Hansen, J Romer, M Jackerott, and N Billestrup
Regulation of pancreatic {beta}-cell mass and proliferation by SOCS-3
J. Mol. Endocrinol.,
October 1, 2005;
35(2):
231 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Hennige, U. Ozcan, T. Okada, U. S. Jhala, M. Schubert, M. F. White, and R. N. Kulkarni
Alterations in growth and apoptosis of insulin receptor substrate-1-deficient {beta}-cells
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E337 - E346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E C Amaral, D. A Cunha, G. F Anhe, M. Ueno, E. M Carneiro, L. A Velloso, S. Bordin, and A. C Boschero
Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy
J. Endocrinol.,
December 1, 2004;
183(3):
469 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fujinaka, D. Sipula, A. Garcia-Ocana, and R. C. Vasavada
Characterization of Mice Doubly Transgenic for Parathyroid Hormone-Related Protein and Murine Placental Lactogen: A Novel Role for Placental Lactogen in Pancreatic {beta}-Cell Survival
Diabetes,
December 1, 2004;
53(12):
3120 - 3130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson
Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans
Endocrinology,
September 1, 2004;
145(9):
4162 - 4175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. NANDI, Y. KITAMURA, C. R. KAHN, and D. ACCILI
Mouse Models of Insulin Resistance
Physiol Rev,
April 1, 2004;
84(2):
623 - 647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Harlan
Gene-Altered Islets for Transplant: Giant Leap or Small Step?
Endocrinology,
February 1, 2004;
145(2):
463 - 466.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Sugden and M. J. Holness
Potential Role of Peroxisome Proliferator-Activated Receptor-{alpha} in the Modulation of Glucose-Stimulated Insulin Secretion
Diabetes,
February 1, 2004;
53(90001):
S71 - 81.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Cui, L. Huang, F. Elefteriou, G. Yang, J. M. Shelton, J. E. Giles, O. K. Oz, T. Pourbahrami, C. Y. H. Lu, J. A. Richardson, et al.
Essential Role of STAT3 in Body Weight and Glucose Homeostasis
Mol. Cell. Biol.,
January 1, 2004;
24(1):
258 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY
Hyperinsulinism in Infancy: From Basic Science to Clinical Disease
Physiol Rev,
January 1, 2004;
84(1):
239 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Friedrichsen, H. E. Richter, J. A. Hansen, C. J. Rhodes, J. H. Nielsen, N. Billestrup, and A. Moldrup
Signal Transducer and Activator of Transcription 5 Activation Is Sufficient to Drive Transcriptional Induction of Cyclin D2 Gene and Proliferation of Rat Pancreatic {beta}-Cells
Mol. Endocrinol.,
May 1, 2003;
17(5):
945 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garcia-Ocana, K. K. Takane, V. T. Reddy, J.-C. Lopez-Talavera, R. C. Vasavada, and A. F. Stewart
Adenovirus-mediated Hepatocyte Growth Factor Expression in Mouse Islets Improves Pancreatic Islet Transplant Performance and Reduces Beta Cell Death
J. Biol. Chem.,
January 3, 2003;
278(1):
343 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Sugden, G. K. Greenwood, N. D. Smith, and M. J. Holness
Peroxisome Proliferator-Activated Receptor-{alpha} Activation during Pregnancy Attenuates Glucose-Stimulated Insulin Hypersecretion in Vivo by Increasing Insulin Sensitivity, without Impairing Pregnancy-Induced Increases in {beta}-Cell Glucose Sensing and Responsiveness
Endocrinology,
January 1, 2003;
144(1):
146 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cebrian, A. Garcia-Ocana, K. K. Takane, D. Sipula, A. F. Stewart, and R. C. Vasavada
Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic {beta}-Cell Death In Vivo and In Vitro
Diabetes,
October 1, 2002;
51(10):
3003 - 3013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kido, J. Nakae, M. L. Hribal, S. Xuan, A. Efstratiadis, and D. Accili
Effects of Mutations in the Insulin-like Growth Factor Signaling System on Embryonic Pancreas Development and beta -Cell Compensation to Insulin Resistance
J. Biol. Chem.,
September 20, 2002;
277(39):
36740 - 36747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Nichols and J. C. Koster
Diabetes and insulin secretion: whither KATP?
Am J Physiol Endocrinol Metab,
September 1, 2002;
283(3):
E403 - E412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yang, K. Yamagata, K. Fukui, Y. Cao, T. Nammo, H. Iwahashi, H. Wang, I. Matsumura, T. Hanafusa, R. Bucala, et al.
Hepatocyte Nuclear Factor-1{alpha} Modulates Pancreatic {beta}-Cell Growth by Regulating the Expression of Insulin-Like Growth Factor-1 in INS-1 Cells
Diabetes,
June 1, 2002;
51(6):
1785 - 1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garcia-Ocana, R. C. Vasavada, A. Cebrian, V. Reddy, K. K. Takane, J.-C. Lopez-Talavera, and A. F. Stewart
Transgenic Overexpression of Hepatocyte Growth Factor in the {beta}-Cell Markedly Improves Islet Function and Islet Transplant Outcomes in Mice
Diabetes,
December 1, 2001;
50(12):
2752 - 2762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Holness and M. C. Sugden
Dexamethasone during Late Gestation Exacerbates Peripheral Insulin Resistance and Selectively Targets Glucose-Sensitive Functions in {beta} Cell and Liver
Endocrinology,
September 1, 2001;
142(9):
3742 - 3748.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|